Gustaf H. Carlson School of Chemistry

Sunny Tam

Sunny Tam, Ph.D.

Research Associate Professor
Carlson School of Chemistry & Biochemistry
Department of Chemistry
Biochemistry and Molecular Biology Program
Clark University
Worcester, MA 01610-1477

Office: S111, Sackler Sciences Center
Phone: (508) 793-7121
Email: stam@clarku.edu

 


Education

B.S. Boston College, Chestnut Hill, MA, 1984
Ph.D. Boston University Medical School, Boston, MA,1990
Postdoctoral Fellow, Harvard University School of Public Health, Boston, MA, 1991-1993

Current Research and Teaching

My current research interest is to apply cutting edge technology, such as protein microarray, bioinformatics, mass spectrometry and proteomic technology, to accelerate our basic understanding of major human diseases. They include diabetes, cancer, cardiovascular or inflammatory diseases. By combining technology and biology, it is now possible to obtain a more complete view of the disease process through a “system biology” approach. This approach allows the integration of cellular signal transduction pathways, identification of protein or metabolite expression as useful biomarkers and post-translational modifications to explain disease mechanism. Meaningful databases through proteomic profiling or metabolites identification will significantly improve our scientific research initiatives. After the discovery phase, scientific clinical validation of the findings with animal models and human patient samples will greatly accelerate their clinical applications and biotechnology development. New diagnostic tool and treatment regimen can emerge. This will be the true essence of translational science with a personal medicine focus. For instance, the application of biomarkers to stratify patient population can significantly impact the testing of herbal mixture, biosimilars, protein or drug therapeutics and its related determination of toxicity, production QC and bioassays.

Selected Publications

Tang JK, Xu Y, Muhlmann GM, Zare F, Khin Y, Tam SW. Temperature shift effect on the chlorobaculum tepidum chlorosomes. Photosynthesis Research, 115(1): 23-41, 2013.

Low HP, Tiwari A, Janjanam J, Qiu L, Chang CI, Strohsnitter WC, Norwitz ER, Tam SW, Evans JE, Green KM, Paulo JA, Lambe M, Hsieh CC. Screening preeclamptic cord plasma for proteins associated with decreased breast cancer susceptibility. Genomics Proteomics Bioinformatics, 11(6): 335-44, 2013.

Lan WK., Horn MJ., Urano F., Kopoyan A., and Tam SW. Subcellular Fractionation Using Step-Wise Density Extraction for Mass Spectrometry Analysis. Methods in Proteomic Sample Preparation, Springer, Chapter 12, 2011.

Kruger AJ, Yang C, Tam SW, Hinerfeld D, Evans JE, Green KM, Leszyk J, Guberski DL, Mordes JP, Greiner DL, Rossini AA and Bortell R. Haptoglobin is an early serum biomarker of virally induced type 1 diabetes in BBDR rats. Experimental Biology and Medicine, 235(11): 1328-1337, 2010.

Byerley LO, Leamy L, Tam SW, Chou CW, Ravussin E, Development of a serum profile for healthy aging. Journal of Gerontology, 4: 497-507, 2010.

Romero R, Kusanovic JP, Gotsch F, Erez O, Vaisbuch E, Mazaki-Tovi S, Moser A, Tam SW, Leszyk J, Master SR, Juhasz P, Pacora P, Ogge G, Gomez R, Yoon BH, Yeo L, Hassan SS, Rogers WT.Isobaric labeling and tandem mass spectrometry: a novel approach for profiling and quantifying proteins differentially expressed in amniotic fluid in preterm labor with and without intra-amniotic infection/inflammation. Journal of Maternal Fetal Neonatal Medicine. 23(4): 261-280, 2010.

Tam SW. Electrophoretic prefractionation: New commercial tools from an old concept. Expert Review, Proteomics. 3(4): 379-81, 2006.

Davis MA, Hinerfeld D, Joseph S, Hui YH, Huang N, Leszyk J, Rutherford-Bethard J, Tam SW. Proteomic analysis of rat liver phosphoproteins after treatment with protein kinase inhibitor H89. Journal of Pharmacololgy and Experimental Therapeutics. 318(2): 589-595, 2006.

Tam SW, Huang L, Hinerfeld D, Innamorati D, Fang XM, Zhang WW, Pirro J & Feitelson JS. Novel plasma protein separation strategy using multiple avian IgY antibodies for proteomic analysis. Separation Methods In Proteomics, edited by Smejkal and Lazarev., 2005.

Tam SW, Pirro J and Hinerfeld D. Depletion and fractionation technologies in plasma proteomic analysis. Expert Review in Proteomics. 1(4): 1- 10, 2004.

Hinerfeld D, Innamorati D, Pirro J, and Tam SW. Serum/plasma depletion with chicken IgY antibodies for proteomic analysis from multiple mammalian species. Journal of Biomolecular Techniques. 15: 184-190, 2004.

Tam SW, Demissie S, Thomas D and Daeron M. A bispecific antibody against human IgE and human FcgRII that inhibits antigen-induced histamine release by human mast cells and basophils. Allergy 59: 772-780, 2004.

Tam SW, Wiese R, Lee S, Gilmore J and Kumble KD. Simultaneous analysis of human Th1/Th2 cytokines using microarray. Journal of Immunol Methods, 261: 157-165, 2002.

Huang JX, Mehrens D, Wiese R, Lee S, Tam SW, Daniel S, Gilmore J, Shi M, and Lashkari D. High-throughput genomic and proteomic analysis using microarray technology. Clinical Chemistry. 47: 1912-1916, 2001.

Cho C, Tam SW, Demissie S and Oh CK. Plasminogen activator inhibitor for airway remodeling. Journal of Immunology, 165: 3154-3161, 2000.